Clinical Protocol CERN Feasibility Study
Part of paid clinical trials in Irvine, California.
- Sponsor
- Cern Corporation
- Study ID
- NCT06933420
- Status
- Recruiting
Conditions
- Bacterial Vaginosis
- Fungal Vaginal Infections
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cern Device — DEVICEThe Cern Device is an Intravaginal device utilizing low level microbicidal visible light at a 450nm low level microbicidal light, in visible spectrum for treatment of vaginitis, including both bacterial vaginosis and fungal vaginitis.
Study Details
The goal of this clinical trial is to learn if the intravaginal Cern device works to treat bacterial vaginosis and fungal vaginitis in premenopausal women. It will also learn about the safety of the device. The main questions it aims to answer are: Does the device accomplish symptom resolution and negative diagnostic tests post-treatment? What medical problems do participants have when using the intravaginal device? Participants will use the investigational intravaginal device for 5 consecutive days, participate in teleconferences and weekly follow-ups, attend in-clinic visits, and maintain a study diary.
Key Dates
- Start date
- Nov 6, 2024
- Status verified
- Apr 2025
- Primary completion
- May 31, 2025
- Completion
- May 31, 2025
Study Design
- Enrollment
- 9 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Bacterial Vaginosis and Fungal VaginitisFor bacterial vaginosis, the participants receive 30-minute daily treatment with the Cern Device for 5 days. For fungal vaginitis, the participants receive 60-minute daily treatment with the Cern Device for 5 days.
Primary Outcome Measure
Resolution of Clinical Symptoms [ Time Frame: Day 1 to Day 28 (post-treatment) ]
Central Contacts
- Gregg Klang(949) 306-7160
- Melanie Santos(650) 353-6353
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Akerman Med | Irvine | California | 92618 | |
| Akerman Med | Orange | California | 92868 | |
| Akerman Med | Santa Ana | California | 92707 |
Find similar trials in Irvine, CA
Related Studies
- Vaginal Ecosystem and Network in the United States StudyEnrolling By Invitation · Vaginal Biome Science · Fullerton, California
- A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections.Not Yet Recruiting · Happy V · Santa Monica, California
- Prospective Data Bank Creation to Study Vaginal ConditionsRecruiting · Texas Tech University Health Sciences Center · Midland, Texas
- Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal MicrobiomeEARLY_PHASE1 · Recruiting · Queen's Medical Center · Honolulu, Hawaii